Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China
· Delayed Price · Currency is CNY 58.77
-1.93 (-3.18%)
At close: Jun 5, 2025, 2:57 PM CST
SHA:688192 Market Cap
SHA:688192 has a market cap or net worth of 27.89 billion as of June 5, 2025. Its market cap has increased by 49.26% in one year.
Market Cap
27.89B
Enterprise Value
28.42B
Revenue
438.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
58.77
Market Cap Chart
Since December 10, 2021, SHA:688192's market cap has increased from 16.44B to 27.89B, an increase of 69.63%. That is a compound annual growth rate of 16.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2025 | 27.89B | 61.78% |
| Dec 31, 2024 | 17.24B | -11.74% |
| Dec 29, 2023 | 19.53B | 21.84% |
| Dec 30, 2022 | 16.03B | 7.16% |
| Dec 31, 2021 | 14.96B | -9.01% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 362.72B |
| Shenzhen Mindray Bio-Medical Electronics | 273.17B |
| WuXi AppTec | 181.57B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.11B |
| Sichuan Biokin Pharmaceutical | 120.77B |
| Aier Eye Hospital Group | 115.34B |
| Shanghai United Imaging Healthcare | 112.70B |
| Yunnan Baiyao Group Co.,Ltd | 100.78B |